Paul is a primary leader in healthcare projects, with a specific focus on pharma and biopharma. He has a rich history to draw on, having worked as a research chemist for the best part of 20 years, mainly in pharmaceutical R&D.

Paul’s first-ever job was as a research scientist at Pfizer, working on trying to make new antifungal drugs. He then went on to work as a research chemist for the best part of 20 years, mainly in pharmaceutical R&D at Pfizer and AstraZeneca, before moving into grant writing more than five years ago.

One of Paul’s career highlights so far was when he finished his lab career as a synthetic radiochemist preparing radiolabelled drugs, which he describes as “challenging but also extremely enjoyable”. During that time, Paul developed new methodologies that are used to expand on the limited ways that radiolabelled compounds can be made. He also presented this work at international conferences.

‍

‍